Epigallocatechin-3-gallate suppresses galactose-alpha1,4-galactose-1beta,4-glucose ceramide expression in TNF-alpha stimulated human intestinal epithelial cells through inhibition of MAPKs and NF-kappaB. - Wikidata - wikimedia - TriplyDB

Epigallocatechin-3-gallate suppresses galactose-alpha1,4-galactose-1beta,4-glucose ceramide expression in TNF-alpha stimulated human intestinal epithelial cells through inhibition of MAPKs and NF-kappaB.

Epigallocatechin-3-gallate suppresses galactose-alpha1,4-galactose-1beta,4-glucose ceramide expression in TNF-alpha stimulated human intestinal epithelial cells through inhibition of MAPKs and NF-kappaB.

http://www.wikidata.org/entity/Q37433674

about

Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease.Green tea catechins suppress NF-κB-mediated inflammatory responses: relevance to nutritional management of inflammation.

P2860

Q36320770-A8B74F92-78CF-4C45-92D8-BB4CC3139C49 Q46691796-BD8F7E75-7A34-4311-A126-3AA356E049E2

P2860

Epigallocatechin-3-gallate suppresses galactose-alpha1,4-galactose-1beta,4-glucose ceramide expression in TNF-alpha stimulated human intestinal epithelial cells through inhibition of MAPKs and NF-kappaB.

http://www.wikidata.org/entity/Q37433674

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2005

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Epigallocatechin-3-gallate sup ...... bition of MAPKs and NF-kappaB.

@en

Epigallocatechin-3-gallate sup ...... bition of MAPKs and NF-kappaB.

@nl

type

label

Epigallocatechin-3-gallate sup ...... bition of MAPKs and NF-kappaB.

@en

Epigallocatechin-3-gallate sup ...... bition of MAPKs and NF-kappaB.

@nl

prefLabel

Epigallocatechin-3-gallate sup ...... bition of MAPKs and NF-kappaB.

@en

Epigallocatechin-3-gallate sup ...... bition of MAPKs and NF-kappaB.

@nl

P1433

Q37433674-63A86945-2C6F-4B32-9D76-8F3D6E23A827

P1476

Q37433674-45FAD2D7-A6E2-4B87-A68C-642FBA7488A7

P2093

Q37433674-11C64A44-B211-4386-9FA9-7838B2F0E144

Q37433674-12C70702-30DD-4843-A95A-FBCDFEF194AA

Q37433674-793A13E6-74D5-490B-8726-6EA7D053DAAA

Q37433674-83CD9FE8-E7AE-4073-886B-98F0B8BE112C

Q37433674-8EFCE281-1634-4F69-ABEE-FB3AD5295A15

Q37433674-E0C6B18C-EFAE-4E4E-8EB6-66F9AA2A0BF7

P2860

Q37433674-01E8DFB7-AD4E-4673-9AED-B00EDEADB133

Q37433674-066AD189-D83F-41EB-983D-44B77382A909

Q37433674-09E7E7D5-DA07-4627-A105-67405FDB1B92

Q37433674-10179D02-E97A-4DF7-9269-32E1FE0B0E28

Q37433674-115473DA-1322-451A-8A58-BEAA365A4130

Q37433674-1E7361DA-9232-4778-B710-E35CB1B31AC5

Q37433674-21044B69-7528-4BCD-8F12-56CBB0FCCDED

Q37433674-23F0A4E9-F23D-4929-8A48-72102C1C52FC

Q37433674-2A0C1C54-451A-4BF8-A221-51BEC0BE9DBE

Q37433674-326A1F77-7D9A-441C-9EFC-95F179C35B5D

P304

Q37433674-47C22501-6871-4872-A60A-923C90E47B2D

P31

Q37433674-85EC628A-192C-4678-ADD9-9DBCC77911C0

P356

Q37433674-820B4A07-DD75-4130-86DC-427693F0E13F

P433

Q37433674-E32DEA71-2CE5-4D08-84F3-38AE77505634

P478

Q37433674-31720768-FB08-407F-B6BB-1E7643819BAD

P577

Q37433674-79750998-EAA8-4B13-81E1-6C96996CCE14

P5875

Q37433674-E56E13DC-2F9B-45A0-A8FB-C78A1879594D

P698

Q37433674-CDAC410C-0B10-404C-A35C-98CF49924FC6

P921

Q37433674-EF63A59B-94A9-4C23-ADCE-4DF8183275DB

P932

Q37433674-8B49EEB7-B7F1-4E89-BD77-0B61947F4F94

P356

JKMS.2005.20.4.548

P1433

Journal of Korean Medical Science

P1476

Epigallocatechin-3-gallate sup ...... bition of MAPKs and NF-kappaB.

@en

P2093

Chang-Min Lee

http://www.w3.org/2001/XMLSchema#string

Dong-Oh Moon

http://www.w3.org/2001/XMLSchema#string

Gi-Young Kim

http://www.w3.org/2001/XMLSchema#string

Hee-Jeong Lee

http://www.w3.org/2001/XMLSchema#string

Se-Rim Choi

http://www.w3.org/2001/XMLSchema#string

Yeong-Min Park

http://www.w3.org/2001/XMLSchema#string

P2860

Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections

Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome.

Tumor necrosis factor and interleukin 1 induce expression of the glycolipid verotoxin receptor in human endothelial cells. Implications for the pathogenesis of the haemolytic uraemic syndrome.

Virulence of enterohemorrhagic Escherichia coli: role of molecular crosstalk.

Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry.

Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.

Tea antioxidants in cancer chemoprevention.

Persistence of local cytokine production in shigellosis in acute and convalescent stages.

Translocation of Shiga toxin across polarized intestinal cells in tissue culture.

Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells

P304

548-554

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3346/JKMS.2005.20.4.548

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

246743654

http://www.w3.org/2001/XMLSchema#string

P698

16100442

http://www.w3.org/2001/XMLSchema#string

P921

P932

2782146

http://www.w3.org/2001/XMLSchema#string